Establishment and characterization of chemotherapy-enriched sphere-forming cells with stemness phenotypes as a new cell line (BAG
Cancer stem cells
Gastric cancer
Novel cell line
Journal
Medical oncology (Northwood, London, England)
ISSN: 1559-131X
Titre abrégé: Med Oncol
Pays: United States
ID NLM: 9435512
Informations de publication
Date de publication:
29 Sep 2022
29 Sep 2022
Historique:
received:
29
01
2022
accepted:
26
04
2022
entrez:
29
9
2022
pubmed:
30
9
2022
medline:
4
10
2022
Statut:
epublish
Résumé
Gastric cancer is a malignancy with a high mortality rate worldwide. Cancer stem cells (CSCs) are a small subpopulation of tumor cells that possess the tumor-initiating ability, self-renewal capacity, and high resistance to conventional therapies. Due to the diversity and complexity of human tumors, new cell lines are urgently needed to supply clinically and physiologically relevant cancer models. Here, we report establishing a novel cell line (BAG
Identifiants
pubmed: 36175578
doi: 10.1007/s12032-022-01742-8
pii: 10.1007/s12032-022-01742-8
doi:
Substances chimiques
Epithelial Cell Adhesion Molecule
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
201Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Herrero R, Parsonnet J, Greenberg ER. Prevention of gastric cancer. JAMA. 2014;312:1197–8. https://doi.org/10.1001/jama.2014.10498 .
doi: 10.1001/jama.2014.10498
pubmed: 25247512
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. https://doi.org/10.3322/caac.21262 .
doi: 10.3322/caac.21262
pubmed: 25651787
Gillet JP, Calcagno AM, Varma S, Marino M, Green LJ, Vora MI, Patel C, Orina JN, Eliseeva TA, Singal V, Padmanabhan R, Davidson B, Ganapathi R, Sood AK, Rueda BR, Ambudkar SV, Gottesman MM. Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci USA. 2011;108:18708–13. https://doi.org/10.1073/pnas.1111840108 .
doi: 10.1073/pnas.1111840108
pubmed: 22068913
pmcid: 3219108
Roth AD. Chemotherapy in gastric cancer: a never ending saga. Ann Oncol. 2003;14:175–7. https://doi.org/10.1093/annonc/mdg081 .
doi: 10.1093/annonc/mdg081
pubmed: 12562640
Abbaszadegan MR, Bagheri V, Razavi MS, Momtazi AA, Sahebkar A, Gholamin M. Isolation, identification, and characterization of cancer stem cells: A review. J Cell Physiol. 2017;232:2008–18. https://doi.org/10.1002/jcp.25759 .
doi: 10.1002/jcp.25759
pubmed: 28019667
Eaves CJ. Cancer stem cells: here, there, everywhere? Nature. 2008;456:581–2. https://doi.org/10.1038/456581a .
doi: 10.1038/456581a
pubmed: 19052611
Zhang X, Yashiro M, Qiu H, Nishii T, Matsuzaki T, Hirakawa K. Establishment and characterization of multidrug-resistant gastric cancer cell lines. Anticancer Res. 2010;30:915–21.
pubmed: 20393015
Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–11. https://doi.org/10.1038/35102167 .
doi: 10.1038/35102167
pubmed: 11689955
Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009;27:1006–20. https://doi.org/10.1002/stem.30 .
doi: 10.1002/stem.30
pubmed: 19415765
Li L, Li Y, Wang L, Wu Z, Ma H, Shao J, Li D, Yu H, Nian W, Wang D. Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells. Oncol Lett. 2017;14:3989–96. https://doi.org/10.3892/ol.2017.6683 .
doi: 10.3892/ol.2017.6683
pubmed: 28959362
pmcid: 5607651
Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255:1707–10. https://doi.org/10.1126/science.1553558 .
doi: 10.1126/science.1553558
pubmed: 1553558
Rybak AP, He L, Kapoor A, Cutz JC, Tang D. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells. Biochim Biophys Acta. 2011;1813:683–94. https://doi.org/10.1016/j.bbamcr.2011.01.018 .
doi: 10.1016/j.bbamcr.2011.01.018
pubmed: 21277911
Chen T, Yang K, Yu J, Meng W, Yuan D, Bi F, Liu F, Liu J, Dai B, Chen X, Wang F, Zeng F, Xu H, Hu J, Mo X. Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res. 2012;22:248–58. https://doi.org/10.1038/cr.2011.109 .
doi: 10.1038/cr.2011.109
pubmed: 21727908
Bagheri V, Abbaszadegan MR, Memar B, Motie MR, Asadi M, Mahmoudian RA, Gholamin M. Induction of T cell-mediated immune response by dendritic cells pulsed with mRNA of sphere-forming cells isolated from patients with gastric cancer. Life Sci. 2019;219:136–43. https://doi.org/10.1016/j.lfs.2019.01.016 .
doi: 10.1016/j.lfs.2019.01.016
pubmed: 30641083
Park JG, Frucht H, LaRocca RV, Bliss DP Jr, Kurita Y, Chen TR, Henslee JG, Trepel JB, Jensen RT, Johnson BE, et al. Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 1990;50:2773–80.
pubmed: 2158397
Lima EM, Rissino JD, Harada ML, Assumpcao PP, Demachki S, Guimaraes AC, Casartelli C, Smith MA, Burbano RR. Conventional cytogenetic characterization of a new cell line, ACP01, established from a primary human gastric tumor. Braz J Med Biol Res. 2004;37:1831–8. https://doi.org/10.1590/s0100-879x2004001200008 .
doi: 10.1590/s0100-879x2004001200008
pubmed: 15558189
Park JG, Yang HK, Kim WH, Chung JK, Kang MS, Lee JH, Oh JH, Park HS, Yeo KS, Kang SH, Song SY, Kang YK, Bang YJ, Kim YH, Kim JP. Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer. 1997;70:443–9. https://doi.org/10.1002/(sici)1097-0215(19970207)70:4%3c443::aid-ijc12%3e3.0.co;2-g .
doi: 10.1002/(sici)1097-0215(19970207)70:4<443::aid-ijc12>3.0.co;2-g
pubmed: 9033653
Nakanishi H, Yasui K, Ikehara Y, Yokoyama H, Munesue S, Kodera Y, Tatematsu M. Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis. Clin Exp Metastasis. 2005;22:137–47. https://doi.org/10.1007/s10585-005-6526-z .
doi: 10.1007/s10585-005-6526-z
pubmed: 16086234
Leal MF, Martins do Nascimento JL, da Silva CE, Vita Lamarao MF, Calcagno DQ, Khayat AS, Assumpcao PP, Cabral IR, de Arruda Cardoso Smith M, Burbano RR. Establishment and conventional cytogenetic characterization of three gastric cancer cell lines. Cancer Genet Cytogenet. 2009;195:85–91. https://doi.org/10.1016/j.cancergencyto.2009.04.020 .
doi: 10.1016/j.cancergencyto.2009.04.020
pubmed: 19837275
Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y, Toge T, Sugano K, Hirohashi S. Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci. 2004;95:575–82. https://doi.org/10.1111/j.1349-7006.2004.tb02489.x .
doi: 10.1111/j.1349-7006.2004.tb02489.x
pubmed: 15245593
Yang YC, Wang SW, Hung HY, Chang CC, Wu IC, Huang YL, Lin TM, Tsai JL, Chen A, Kuo FC, Wang WM, Wu DC. Isolation and characterization of human gastric cell lines with stem cell phenotypes. J Gastroenterol Hepatol. 2007;22:1460–8. https://doi.org/10.1111/j.1440-1746.2007.05031.x .
doi: 10.1111/j.1440-1746.2007.05031.x
pubmed: 17645461
Bagheri V, Memar B, Behzadi R, Aliakbarian M, Jangjoo A, Bahar MM, Talebi S, Gholamin M, Abbaszadegan MR. Corrigendum: isolation and identification of chemotherapy-enriched sphere-forming cells from a patient with gastric cancer. J Cell Physiol. 2019;234:9878. https://doi.org/10.1002/jcp.27578 .
doi: 10.1002/jcp.27578
Bagheri V, Memar B, Behzadi R, Aliakbarian M, Jangjoo A, Bahar MM, Talebi S, Gholamin M, Abbaszadegan MR. Isolation and identification of chemotherapy-enriched sphere-forming cells from a patient with gastric cancer. J Cell Physiol. 2018;233:7036–46. https://doi.org/10.1002/jcp.26627 .
doi: 10.1002/jcp.26627
pubmed: 29744869
Ghazaey S, Mirzaei F, Ahadian M, Keifi F, Semiramis T, Abbaszadegan MR. Pattern of chromosomal aberrations in patients from north east Iran. Cell J. 2013;15:258–65.
pubmed: 24027668
pmcid: 3769609
Howe B, Umrigar A, Tsien F. Chromosome preparation from cultured cells. J Vis Exp. 2014. https://doi.org/10.3791/50203 .
doi: 10.3791/50203
pubmed: 24513647
pmcid: 4091199
Seabright M. A rapid banding technique for human chromosomes. Lancet. 1971;2:971–2. https://doi.org/10.1016/s0140-6736(71)90287-x .
doi: 10.1016/s0140-6736(71)90287-x
pubmed: 4107917
Gay L, Baker AM, Graham TA. Tumour cell heterogeneity. F1000Res. 2016. https://doi.org/10.12688/f1000research.7210.1 .
doi: 10.12688/f1000research.7210.1
pubmed: 26973786
pmcid: 4776671
Sulaiman A, McGarry S, El-Sahli S, Li L, Chambers J, Phan A, Cote M, Cron GO, Alain T, Le Y, Lee SH, Liu S, Figeys D, Gadde S, Wang L. Co-targeting bulk tumor and CSCs in clinically translatable tnbc patient-derived xenografts via combination nanotherapy. Mol Cancer Ther. 2019;18:1755–64. https://doi.org/10.1158/1535-7163.MCT-18-0873 .
doi: 10.1158/1535-7163.MCT-18-0873
pubmed: 31308079
Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, Lomas C, Mendiola M, Hardisson D, Eccles SA. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 2012;10:29. https://doi.org/10.1186/1741-7007-10-29 .
doi: 10.1186/1741-7007-10-29
pubmed: 22439642
pmcid: 3349530
Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 2009;4:309–24. https://doi.org/10.1038/nprot.2008.226 .
doi: 10.1038/nprot.2008.226
pubmed: 19214182
Hadjimichael C, Chanoumidou K, Papadopoulou N, Arampatzi P, Papamatheakis J, Kretsovali A. Common stemness regulators of embryonic and cancer stem cells. World J Stem Cells. 2015;7:1150–84. https://doi.org/10.4252/wjsc.v7.i9.1150 .
doi: 10.4252/wjsc.v7.i9.1150
pubmed: 26516408
pmcid: 4620423
Matsuoka J, Yashiro M, Sakurai K, Kubo N, Tanaka H, Muguruma K, Sawada T, Ohira M, Hirakawa K. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res. 2012;174:130–5. https://doi.org/10.1016/j.jss.2010.11.903 .
doi: 10.1016/j.jss.2010.11.903
pubmed: 21227461
Huang ZJ, Wang R, Luo WY, Yi WC, Zeng YY, Luo Q. Expression of OCT4 in gastric cancer cell lines and its significance. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012;43:812–5.
pubmed: 23387203
Chen B, Zhu Z, Li L, Ye W, Zeng J, Gao J, Wang S, Zhang L, Huang Z. Effect of overexpression of Oct4 and Sox2 genes on the biological and oncological characteristics of gastric cancer cells. Onco Targets Ther. 2019;12:4667–82. https://doi.org/10.2147/OTT.S209734 .
doi: 10.2147/OTT.S209734
pubmed: 31417271
pmcid: 6592062
Zhong XY, Zhang LH, Jia SQ, Shi T, Niu ZJ, Du H, Zhang GG, Hu Y, Lu AP, Li JY, Ji JF. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Histopathology. 2008;52:560–8. https://doi.org/10.1111/j.1365-2559.2008.02971.x .
doi: 10.1111/j.1365-2559.2008.02971.x
pubmed: 18312357
Zhang JG, Zhao J, Xin Y. Significance and relationship between Cripto-1 and p-STAT3 expression in gastric cancer and precancerous lesions. World J Gastroenterol. 2010;16:571–7. https://doi.org/10.3748/wjg.v16.i5.571 .
doi: 10.3748/wjg.v16.i5.571
pubmed: 20128024
pmcid: 2816268
Han ME, Jeon TY, Hwang SH, Lee YS, Kim HJ, Shim HE, Yoon S, Baek SY, Kim BS, Kang CD, Oh SO. Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research. Cell Mol Life Sci. 2011;68:3589–605. https://doi.org/10.1007/s00018-011-0672-z .
doi: 10.1007/s00018-011-0672-z
pubmed: 21448722
Abbaszadegan MR, Mojarrad M, Moghbeli M. Role of extra cellular proteins in gastric cancer progression and metastasis: an update. Genes Environ. 2020;42:18. https://doi.org/10.1186/s41021-020-00157-z .
doi: 10.1186/s41021-020-00157-z
pubmed: 32467737
pmcid: 7227337
Mayer B, Jauch KW, Gunthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP. De-novo expression of CD44 and survival in gastric cancer. Lancet. 1993;342:1019–22. https://doi.org/10.1016/0140-6736(93)92879-x .
doi: 10.1016/0140-6736(93)92879-x
pubmed: 7692200
Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GY, Bliss J, Vincent-Salomon A, Pantel K. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005;353:793–802. https://doi.org/10.1056/NEJMoa050434 .
doi: 10.1056/NEJMoa050434
pubmed: 16120859
Pantel K, Woelfle U. Detection and molecular characterisation of disseminated tumour cells: implications for anti-cancer therapy. Biochim Biophys Acta. 2005;1756:53–64. https://doi.org/10.1016/j.bbcan.2005.07.002 .
doi: 10.1016/j.bbcan.2005.07.002
pubmed: 16099109
Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, Kelland LR, Harrison M, Virmani A, Ward TH, Ayres KL, Debenham PG. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA. 2001;98:8012–7. https://doi.org/10.1073/pnas.121616198 .
doi: 10.1073/pnas.121616198
pubmed: 11416159
pmcid: 35459
Institute ANS (2011) Authentication of human cell lines: standardization of STR profiling. ANSI/ATCC ASN-0002-2011. Accessed from http://webstore.ansi.org